HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome

This publication has 25 references indexed in Scilit:

• An Immunohistochemical Study of HER-2 Expression in Feline Mammary Tumours
  Journal of Comparative Pathology, 2010
• Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene
  The Veterinary Journal, 2009
• Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study
  BMC Cancer, 2007
• Overexpression of HER-2 in Feline Invasive Mammary Carcinomas: An Immunohistochemical Survey and Evaluation of Its Prognostic Potential
  Veterinary Pathology, 2005
• Oncogene HER-2 in Canine Mammary Gland Carcinomas
  Breast Cancer Research and Treatment, 2003
• Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
  Journal of Clinical Oncology, 2002
• Her-2/neu gene amplification compared with HER-2/neu protein overexpression on ultrasound guided core-needle biopsy specimens of breast carcinoma
  Pathology and Oncology Research, 2001
• HER-2/neu in Breast Cancer: Interobserver Variability and Performance of Immunohistochemistry with 4 Antibodies Compared with Fluorescent In Situ Hybridization
  Laboratory Investigation, 2001
• Immunohistochemical Analysis of c-yes and c-erbB-2 Oncogene Products and p53 Tumor Suppressor Protein in Canine Mammary Tumors
  The Journal of Veterinary Medical Science, 1999
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
  Histopathology, 1991